Hi-Line Capital Management’s Merck MRK Stock Holding History

Hi-Line Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-80,534	Closed	-$10.7M	–	38
2024 Q1	$10.7M	Buy	80,534 +1,066	+1%	+$131K	3.79%	11
2023 Q4	$8.72M	Sell	79,468 -7,737	-9%	-$803K	3.38%	12
2023 Q3	$9.04M	Sell	87,205 -190	-0.2%	-$20.5K	3.33%	12
2023 Q2	$10.1M	Sell	87,395 -10,654	-11%	-$1.21M	3.77%	13
2023 Q1	$10.5M	Buy	98,049 +780	+0.8%	+$84.2K	3.58%	14
2022 Q4	$10.9M	Buy	97,269 +323	+0.3%	+$33K	3.35%	14
2022 Q3	$8.42M	Buy	96,946 +2,217	+2%	+$198K	3.39%	14
2022 Q2	$8.7M	Buy	94,729 +2,518	+3%	+$223K	3.31%	15
2022 Q1	$7.63M	Buy	92,211 +871	+1%	+$68.7K	2.6%	17
2021 Q4	$7.06M	Buy	91,340 +106	+0.1%	+$8.44K	2.6%	17
2021 Q3	$6.91M	Buy	91,234 +2,846	+3%	+$216K	2.47%	18
2021 Q2	$6.93M	Sell	88,388 -3,860	-4%	-$287K	2.64%	18
2021 Q1	$6.79M	Buy	+92,248	New	+$6.8M	2.72%	18

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hi-Line Capital Management's MRK Position: Q2 2024 in Review

Hi-Line Capital Management sold out of Merck (MRK) in Q2 2024, closing a stake of 80,534 shares — an estimated $10.7M sold.

Hi-Line Capital Management first reported a position in MRK in Q1 2021 and held it in 13 quarters. The position peaked at $10.9M in Q4 2022. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

Hi-Line Capital Management reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
Hi-Line Capital Management sold 80,534 Merck shares in Q2 2024, an estimated $10.7M.
Hi-Line Capital Management first reported a position in Merck in Q1 2021 and held it in 13 quarters.
Hi-Line Capital Management's Merck position peaked at $10.9M in Q4 2022.
3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Hi-Line Capital Management's 13F filing for Q2 2024, filed 31 Jul 2024.